Brief: Novakand Pharma Extends Peter Selin's CEO Employment
18/03/2026 11:56
March 18 (Reuters) - Novakand Pharma AB NOVKAN.ST: EXTENDS PETER SELIN'S CEO EMPLOYMENT UNTIL MAY 31, 2026 Source text: ID:nMFN6Gh6LF Further company coverage: NOVKAN.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing